Training and practice of free cannabis dispensing staff

03/09/2021 6 min read

Cannabis as a substitute for prescription drugs - a cross-sectional study

Almost 50% of respondents said they replace prescription drugs with cannabis.

Cannabis as a Therapeutic Alternative: Emerging Scientific Evidence

Contemporary scientific research has turned its attention to an increasingly relevant phenomenon in healthcare: the use of cannabis as a substitute for prescription medications. A recent cross-sectional study has shed light on this practice, revealing significant data that merits detailed analysis from the perspective of cannabis genetic research.

The results of this research indicate that approximately half of respondents have chosen to use cannabis instead of traditional medications, suggesting the importance of better understanding the specific properties of different cannabis genetics and their cannabinoid and terpene profiles.

Scientific Framework of the Research

The study, conducted by researchers James M. Corroon Jr., Laurie K. Mischley, and Michelle Sexton, arose in response to the notable increase in medicinal cannabis use, particularly for addressing conditions related to chronic pain, anxiety, and depressive states. The primary motivation for this research was based on emerging data suggesting a possible correlation between medical cannabis legalization and reduced use and abuse of prescription medications.

This line of research becomes particularly relevant when we consider the specific characteristics of different cannabis varieties and their unique profiles of active compounds. CBD-rich genetics, for example, are known for their relaxing properties without psychoactive effects, while other varieties have specific terpene profiles that contribute to their distinctive aromatic characteristics.

Methodology and Scope of the Study

The research employed a robust methodological approach, incorporating a total of 2,774 individuals who confirmed having used cannabis at least once during the 90 days prior to the study. Participants were carefully selected through social media platforms and legal cannabis dispensaries located in the state of Washington.

The data collection instrument consisted of an anonymous online questionnaire, specifically designed to examine patterns of substituting prescribed medications with cannabis. This methodology allowed for detailed information to be obtained regarding motivations, frequencies, and types of medications substituted.

Main Findings and Data Analysis

The results obtained reveal significant information about substitution trends. Of the participants who completed the survey, 1,248 respondents, equivalent to 46% of the total, confirmed using cannabis as an alternative to prescription medications.

The most frequently substituted medication categories include:

Narcotics and opiates: 35.8% of reported substitutions
Anxiolytics and benzodiazepines: 13.6% of cases
Antidepressants: 12.7% of substitutions

Statistical analysis revealed a total of 2,473 reported substitutions, equivalent to approximately two medication substitutions per participant. A particularly relevant finding is that the likelihood of medication substitution was 4.59 times higher (95% confidence interval: 3.87-5.43) among medical cannabis users compared to recreational users.

Implications for Cannabis Genetic Research

These findings underscore the importance of ongoing research into specific cannabis genetics and their cannabinoid profiles. The diversity of substituted medications suggests that different varieties, with their unique profiles of active compounds, may be being used to address different conditions.

Genetics with profiles rich in specific cannabinoids, such as CBD, CBG, or particular combinations of THC and CBD, represent valuable genetic material for scientific research. Seed collectors play an important role in preserving this genetic diversity, maintaining varieties that could have significant scientific value.

Additionally, users who reported using cannabis to relieve comorbid pain, anxiety, and depression showed a 1.66 times higher likelihood of substituting prescribed medications, highlighting the relevance of understanding the specific therapeutic profiles of different genetics.

Legal Context and Future Perspectives

The study also examined the influence of the legal framework on substitution patterns. Results indicated that a slightly higher percentage of participants who confirmed substitution resided in regions where medical cannabis use was legal at the time of the survey (47% versus 45%), although this difference did not reach statistical significance.

This observation suggests that legal accessibility may influence substitution decisions, but it is not the only determining factor. The quality of genetic material, cannabinoid and terpene profiles, and knowledge about the specific properties of different varieties also play crucial roles.

Ongoing research in this field is essential to better understand how different cannabis genetics can contribute to user well-being. Cannabis seed collectors indirectly contribute to this research by preserving the genetic diversity that enables future studies on unique profiles of active compounds and their specific properties.